electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. DSX
2. GNK
3. INTC
4. SPCX
5. ACN
6. III
7. SAN
8. TTEC
9. SNY
10. DAL

Go back to electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
(NASDAQ: ECOR) Delayed: 8.43 -0.27 (3.1%)
Previous Close $8.70    52 Week High $ 
Open $8.74    52 Week Low $ 
Day High $8.84    P/E N/A 
Day Low $7.85    EPS $ 
Volume 135,550